Considering neuroleptic maintenance and taper on a continuum. Need for individual rather than dogmatic approach.
Jeste
D V
DV
Department of Psychiatry, University of California, San Diego.
Gilbert
P L
PL
McAdams
L A
LA
Harris
M J
MJ
D014150:Antipsychotic Agents / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D004409:Dyskinesia, Drug-Induced / Q000453:epidemiology / Q000209:etiology; D006801:Humans; D015201:Meta-Analysis as Topic; D011605:Psychoses, Substance-Induced / Q000209:etiology; D012008:Recurrence; D012559:Schizophrenia / Q000188:drug therapy* / Q000517:prevention & control; D013375:Substance Withdrawal Syndrome / Q000453:epidemiology / Q000209:etiology; D016896:Treatment Outcome
D014150:Antipsychotic Agents